As of May 2024 SurgePays has a market cap of $78.86 Million. This makes SurgePays the world's 7551th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $78.86 M | -14.06% |
2023 | $91.77 M | 11.64% |
2022 | $82.2 M | 237.33% |
2021 | $24.36 M | 63.13% |
2020 | $14.93 M | -51.28% |
2019 | $30.65 M | -8.37% |
2018 | $33.45 M | -49.57% |
2017 | $66.34 M | 333.75% |
2016 | $15.29 M | -5.92% |
2015 | $16.25 M | 7443.06% |
2014 | $0.21 M | 42.86% |
2013 | $0.15 M | |
2011 | $1.07 M | 55.06% |
2010 | $0.69 M | -27.85% |
2009 | $0.96 M | -93.92% |
2008 | $15.84 M |
On May 9th, 2024 the market cap of SurgePays was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $360.64 B | 457,177.12% | ๐บ๐ธ USA |
Novartis NVS | $204.46 B | 259,158.40% | ๐จ๐ญ Switzerland |
Stryker Corporation SYK | $126.04 B | 159,714.65% | ๐บ๐ธ USA |
Cooper Companies COO | $18.82 B | 23,763.20% | ๐บ๐ธ USA |
STAAR Surgical STAA | $2.10 B | 2,570.01% | ๐บ๐ธ USA |
CONMED CNMD | $2.16 B | 2,647.05% | ๐บ๐ธ USA |
Integra LifeSciences IART | $1.99 B | 2,427.84% | ๐บ๐ธ USA |